ArticleAntimicrobial agents and chemotherapy2011

Optimizing second-line therapy for drug-resistant tuberculosis: the additive value of sequencing for multiple resistance loci.

Scott K Heysell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.